Keywords :
Animals; Brain/pathology; Carrier Proteins/genetics; Female; Humans; Immunohistochemistry/methods; Male; Mice; Mice, Transgenic; Microscopy, Electron/methods; Models, Genetic; Nerve Tissue Proteins/genetics; Neurotransmitter Agents/metabolism; Positron-Emission Tomography/methods; Purkinje Cells/metabolism; Transgenes; alpha-Synuclein/metabolism
Abstract :
[en] Synphilin-1 has been identified as an interacting protein of alpha-synuclein, Parkin, and LRRK2, proteins which are mutated in familial forms of Parkinson disease (PD). Subsequently, synphilin-1 has also been shown to be an intrinsic component of Lewy bodies in sporadic PD. In order to elucidate the role of synphilin-1 in the pathogenesis of PD, we generated transgenic mice overexpressing wild-type and mutant (R621C) synphilin-1 driven by a mouse prion protein promoter. Transgenic expression of both wild-type and the R621C variant synphilin-1 resulted in increased dopamine levels of the nigrostriatal system in 3-month-old mice. Furthermore, we found pathological ubiquitin-positive inclusions in cerebellar sections and dark-cell degeneration of Purkinje cells. Both transgenic mouse lines showed significant reduction of motor skill learning and motor performance. These findings suggest a pathological role of overexpressed synphilin-1 in vivo and will help to further elucidate the mechanisms of protein aggregation and neuronal cell death.
Scopus citations®
without self-citations
16